Skip to main content

Table 4 Comparison between study groups as regards the CPIS score after treatment (clinical cure)

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

CPIS

Group A

Group B

A/B#

≤ 6

24 (75.0%)

18 (55.0%)

0.185

> 6

8 (25.0%)

14 (45.0%)

  1. #Chi-square test